NMN vs NR: Which NAD+ Precursor Is Right for You?

If you've been researching NAD+ supplements, you've encountered two main options: NMN (Nicotinamide Mononucleotide) and NR (Nicotinamide Riboside). Both are NAD+ precursors. Both have human safety data. So which one should you choose?

The Basic Difference

Think of it this way:

NR (smaller, 2 steps away)
  ↓  + NRK enzyme
NMN (medium, 1 step away)
  ↓  + NMNAT enzyme
NAD+ (the target)

NR is a smaller molecule (255.25 g/mol) that can cross cell membranes easily. It needs to be converted to NMN first, then to NAD+.

NMN is slightly larger (334.22 g/mol) with an extra phosphate group. It requires the Slc12a8 transporter to enter cells, but once inside, it's just one step from NAD+.

Head-to-Head Comparison

The Absorption Debate

This is where the science gets interesting — and controversial.

NR's advantage: Being smaller and lacking a phosphate group, NR can theoretically enter cells through simple diffusion. No special transporter needed.

NMN's counterpoint: The 2019 discovery of the Slc12a8 transporter changed the game. NMN doesn't need to rely on passive diffusion — it has its own dedicated transport system. Some researchers argue this makes NMN absorption more efficient than previously thought.

The honest answer: We don't have a definitive head-to-head human study comparing NMN and NR absorption. Both appear to work. Both raise NAD+ levels. The difference in real-world effectiveness is likely small.

Clinical Evidence Comparison

NMN Human Studies - More studies conducted in Asia (Japan, China) - Strong metabolic data (insulin sensitivity) - Growing body of safety data - Larger trials currently underway

NR Human Studies - More studies conducted in the US and Europe - More extensive safety data (on market longer) - Solid NAD+ elevation data - Backed by ChromaDex, a publicly traded company

Edge: NR has more human data overall due to being on the market longer. NMN is catching up rapidly.

Market Landscape

NR is dominated by Tru Niagen (ChromaDex), which holds key patents on NR synthesis and use. The patent protection means fewer competitors and generally higher prices.

NMN has no single patent holder, creating a more competitive market with more brands and lower prices. This is a double-edged sword: more choices, but more quality variation.

Which Should You Choose?

Choose NMN if: - You want the most direct NAD+ precursor (1-step conversion) - You prefer a competitive market with lower prices - You're interested in sublingual or alternative delivery formats - You value the growing Asian research base

Choose NR if: - You prefer a supplement with more extensive US/European safety data - You want the smaller molecule size for theoretical absorption advantage - You trust the ChromaDex/Tru Niagen brand - Your doctor specifically recommends NR

The real answer: **Both work.** The best supplement is one you take consistently from a reputable brand. The NMN vs NR debate generates clicks and views, but for most users, the difference is marginal.

Our Position

At Mureen, we chose NMN for three reasons:

1. Direct conversion: One enzymatic step to NAD+ 2. No patent monopoly: We can offer competitive pricing without licensing fees 3. Growing evidence base: The NMN research pipeline is extremely active

We're not anti-NR. We're pro-science and pro-transparency. Whichever you choose, demand third-party testing and published COAs.

Explore Mureen NMN →

Read Next

• What Is NMN? A Complete Guide →
• 5 Science-Backed Benefits of NMN →
• The Science of Aging: NAD+ and NMN →